DOCSLIB.ORG

Power Practice Provides the Concentrated Practice Students NCLEX-RN: Need to Earn a Top Score

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Power Practice Provides the Concentrated Practice Students NCLEX-RN: Need to Earn a Top Score TEST PREP/NURSING US $24.95 LearningExpress® All the Practice You Need NCLEX-RN to Succeed on the NCLEX-RN! COMPLETE TEST PREPARATION ® Success on the NCLEX-RN is mandatory to become a registered nurse. NCLEX-RN: Power Practice provides the concentrated practice students NCLEX-RN: need to earn a top score. Inside, you will have access to three full-length practice exams—two in the book, one online—based on the official test, with detailed answer explanations for each answer choice. In addition, this : POWER PRACTICE indispensible study guide provides: POWER PRACTICE Powerful Practice to Help You Pass the NCLEX-RN Exam n THREE NCLEX-RN practice exams for effective test preparation n THREE full-length practice NCLEX-RN exams with n Important information about the exam—what’s on it, when it’s given, detailed answer explanations how to register, and how it’s scored n The perfect supplement to any NCLEX-RN review guide n A customized online score report with comprehensive answer Alicia Culleiton explanations Dr. Yvonne Weideman n The LearningExpress Test Preparation System, which includes stress- reducing and time-budgeting tips instantly scored to an Added value—Access FREE NCLEX-RN Practice Online Visit LearningExpress’s Online Practice Center to: NCLEX-RN exam n Access an NLCEX-RN practice exam—FREE n Receive immediate scoring and detailed answer explanations for all questions n Focus your study with a customized diagnostic report and boost your score to guarantee success ® Boost Your Score! Prepare for a Brighter Future FREE ACCESS to an Instantly Scored Online Practice Exam IT’S LIKE HAVING THE TEST IN ADVANCE! NCLEX-RN is a registered trademark of the National Council of State Boards of Nursing (NCSBN), which neither sponsors nor endorses this product. NCLEX-RN®: POWER PRACTICE ® NEW YORK NCLEX-RN_00_FM_i-viii.indd 3 11/30/12 9:24 AM Copyright © 2013 Learning Express, LLC. All rights reserved under International and Pan American Copyright Conventions. Published in the United States by LearningExpress, LLC, New York. Library of Congress Cataloging-in-Publication Data: NCLEX-RN : power practice.—1st ed. p. ; cm. ISBN 978-1-57685-908-7 I. LearningExpress (Organization) [DNLM: 1. Nursing Care—Examination Questions. 2. Test-Taking Skills—Examination Questions. WY 18.2] 610.73076—dc23 2012032761 Printed in the United States of America 9 8 7 6 5 4 3 2 1 First Edition ISBN-13: 978-1-57685-908-7 For more information or to place an order, contact LearningExpress at: 2 Rector Street 26th Floor New York, NY 10006 Or visit us at: www.learningexpressllc.com NCLEX-RN is a registered trademark of the National Council of State Boards of Nursing (NCSBN), which neither sponsors nor endorses this product. NCLEX-RN_00_FM_i-viii.indd 4 11/30/12 9:24 AM CONTENTS CONTRIBUTORS vii CHAPTER 1 Introduction to the NCLEX-RN® 1 Overview of NCLEX-RN Registering for the Exam What to Expect at the Test Center During the Test What Skills Are Tested? A Note on Guessing Exam Results CHAPTER 2 The LearningExpress Test Preparation System 7 Step 1: Get Information Step 2: Conquer Test Anxiety Step 3: Make a Plan Step 4: Learn to Manage Your Time Step 5: Learn to Use the Process of Elimination Step 6: Reach Your Peak Performance Zone Step 7: Make Final Preparations Step 8: Make Your Preparations Count v NCLEX-RN_00_FM_i-viii.indd 5 11/30/12 9:24 AM –CONTENTS– CHAPTER 3 NCLEX-RN Practice Test 1 21 Questions Answers CHAPTER 4 NCLEX-RN Practice Test 2 93 Questions Answers ADDITIONAL ONLINE PRACTICE 167 vi NCLEX-RN_00_FM_i-viii.indd 6 11/30/12 9:24 AM CONTRIBUTORS Dr. Yvonne Weideman is an Assistant Professor of Nursing at Duquesne University School of Nursing. Her areas of interest are the preparation of students for the NCLEX exam and the use of innovative technology in the classroom to enhance learning. Dr. Weideman has recently developed a model for integrating theory and content through the use of virtual technology entitled “The Virtual Pregnancy Model.” Dr. Alicia Culleiton is an Assistant Clinical Professor at Duquesne University School of Nursing. She currently teaches doctoral-level nursing courses as well as undergraduate NCLEX-RN preparation courses. Dr. Culleiton earned her BSN from the Catholic University of America, her MSN in nursing administration and nursing edu- cation from Indiana University of Pennsylvania, and her doctorate from Chatham University. Her work has been published in nursing and educational journals. Her clinical expertise is in emergency/trauma and critical care nursing, with research interests that include student remediation and NCLEX-RN preparation. Karen Paraska, PhD, CRNP, is assistant professor of nursing at Duquesne University. She has taught a range of graduate nursing courses that include offerings in advanced practice nursing and research methods, as well as undergraduate courses, including NCLEX-RN preparation courses. She is coauthor of several referred articles, including “Cognitive Impairment Associated with Adjuvant Therapy in Breast Cancer” for the journal Psycho-Oncology. vii NCLEX-RN_00_FM_i-viii.indd 7 11/30/12 9:24 AM NCLEX-RN_00_FM_i-viii.indd 8 11/30/12 9:24 AM INTRODUCTION TO THE NCLEX-RN® CHAPTER 1 ongratulations! If you are reading this book, it means that you have graduated or are about to gradu- ate from an accredited registered nurse (RN) program and are interested in preparing for the National CCouncil Licensure Examination for Registered Nurses (NCLEX-RN®) , which will enable you to gain a license as a registered professional nurse. One of the most important ways to begin preparing for the NCLEX-RN is to become familiar with the format of the exam, the process of registering for the exam, what to expect on test day, the subjects the exam covers, and so on. This chapter will help you get started. While the information in this chapter is current as of the date of publication, some details may change as time goes by. For the most recent information, refer to the official National Council of State Boards of Nursing (NCSBN) NCLEX website at https://www.ncsbn.org/nclex.htm. 1 NCLEX-RN_01_1-6.indd 1 11/30/12 9:25 AM –INTRODUCTION TO THE NCLEX-RN ®– Overview of NCLEX-RN .htm.) The nursing board will certify to Pearson VUE that you are eligible to sit for the exam. This results in The NCLEX-RN is a computer-based exam that tests your Authorization to Test (ATT) letter, which must the knowledge, skills, and abilities you’ll need to prac- be shown the day of the exam. The ATT is valid for a tice safely and effectively as an entry-level RN. The time period—from 60 to 365 days—determined by test is administered in a computerized adaptive test- your board of nursing, and the validity time frame ing (CAT) format, which, by adapting to each indi- cannot be extended. For this reason, it is important vidual’s abilities, allows the computer testing program that you schedule your appointment for the exam as to evaluate your abilities more effectively and effi- soon as possible after receiving your ATT. ciently than do more traditional approaches to test- Step-by-step, the registration process looks like ing. While the procedure the program uses is this, as outlined in the “2012 NCLEX® Examination complex, the general principle is fairly simple. With Bulletin”: each answer you record, the computer reassesses your competencies and continues to ask additional ques- 1. Submit an application for licensure to the tions until it is virtually certain about whether your board of nursing where you wish to be licensed. abilities are above or below the level required. 2. Meet all of the board of nursing’s eligibility Given the test’s adaptability, the number of requirements to take the NCLEX. questions it asks—anywhere from 75 to 265 items— 3. Register for the NCLEX with Pearson VUE. is different for each individual. Of this number, 15 are 4. Receive Acknowledgement of Receipt of Regis- pretest questions designed to help test producers tration from Pearson VUE. develop new types of questions; these are not consid- 5. The board of nursing makes you eligible to take ered in your assessment. The exam is not divided into the NCLEX. sections corresponding to content areas, though it is 6. Receive Authorization to Test (ATT) letter from important that you understand what content areas Pearson VUE. are covered to help you prepare (see section “What 7. Schedule your exam with Pearson VUE. Skills Are Tested?”). There is a time limit of six hours, no matter what number of questions you are given. Source: Taken from “2012 NCLEX® Examination Bulletin,” page 2; available at https://www.ncsbn.org/ 2012_NCLEX_Candidate_Bulletin.pdf. Registering for the Exam The fee to register for the exam is $200, which is Registration for the NCLEX-RN is a two-part pro- nonrefundable. You must also pay a fee associated cess: applying for licensure with the board of nursing with the licensure application required by your nurs- in the state or territory from which you are seeking ing board. The registration is valid for a 365-day your license, and registering for the exam with Pear- period, during which the nursing board will establish son VUE, which administers the test. It is advisable to your eligibility. If a candidate doesn’t meet the board’s start both phases at once, so that both can proceed eligibility requirements within that time period, the simultaneously. registration fee is forfeited. You must meet all of your nursing board’s Failing to appear at the scheduled examination requirements for taking the NCLEX-RN. (For a com- time will also result in both the forfeiture of your reg- plete list of the boards of nursing and links to their istration fee and the invalidation of your ATT, unless websites, go to https://www.ncsbn.org/contactbon you reschedule one full business day before your 2 NCLEX-RN_01_1-6.indd 2 11/30/12 9:25 AM –INTRODUCTION TO THE NCLEX-RN ®– scheduled time.
Load more

Recommended publications
  • Physical Esxam
    Pearls in the Musculoskeletal Exam Frank Caruso MPS, PA-C, EMT-P Skin, Bones, Hearts & Private Parts 2019 Examination Key Points • Area that needs to be examined, gown your patients - well exposed • Understand normal functional anatomy • Observe normal activity • Palpation • Range of Motion • Strength/neuro-vascular assessment • Special Tests General Exam Musculoskeletal Overview Physical Exam Preview Watch Your Patients Walk!! Inspection • Posture – Erectness – Symmetry – Alignment • Skin and subcutaneous tissues – Swelling – Redness – Masses Inspection • Extremities – Size – Deformities – Enlargement – Alignment – Contour – Symmetry Inspection • Muscles – Bilateral symmetry – Hypertrophy – Atrophy – Fasciculations – Spasms Palpation • Palpate bones, joints, and surrounding muscles for the following: – Heat – Tenderness – Swelling – Fluctuation – Crepitus – Resistance to pressure – Muscle tone Muscles • Size and strength affected by the following: – Genetics – Exercise – Nutrition • Muscles move joints through range of motion (ROM). Muscle Strength • Compare bilateral muscles – Strength – Symmetry – Equality – Resistance End Feel Think About It!! • The sensation the examiner feels in the joint as it reaches the end of the range of motion of each passive movement • Bone to bone: This is hard, unyielding – normal would be elbow extension. • Soft–tissue approximation: yielding compression that stops further movement – elbow and knee flexion. End Feel • Tissue stretch: hard – springy type of movement with a slight give – toward the end of range of motion – most common type of normal end feel : knee extension and metacarpophalangeal joint extension. Abnormal End Feel • Muscle spasm: invoked by movement with a sudden dramatic arrest of movement often accompanied by pain - sudden hard – “vibrant twang” • Capsular: Similar to tissue stretch but it does not occur where one would expect – range of motion usually reduced.
    [Show full text]
  • Abdomen and Superficial Structures Including Introductory Pediatric and Musculoskeletal
    National Education Curriculum Specialty Curricula Abdomen and Superficial Structures Including Introductory Pediatric and Musculoskeletal Abdomen and Superficial Structures Including Introductory Pediatric and Musculoskeletal Table of Contents Section I: Biliary ........................................................................................................................................................ 3 Section II: Liver ....................................................................................................................................................... 19 Section III: Pancreas ............................................................................................................................................... 35 Section IV: Renal and Lower Urinary Tract ........................................................................................................ 43 Section V: Spleen ..................................................................................................................................................... 67 Section VI: Adrenal ................................................................................................................................................. 75 Section VII: Abdominal Vasculature ..................................................................................................................... 81 Section VIII: Gastrointestinal Tract (GI) .............................................................................................................. 91
    [Show full text]
  • Screening for Developmental Dysplasia of the Hip
    Screening for Developmental Dysplasia of the Hip: A Systematic Literature Review for the U.S. Preventive Services Task Force Scott A. Shipman, MD, MPH1 Mark Helfand, MD, MPH2 Virginia A. Moyer, MD, MPH3 Barbara P. Yawn, MD, MSc4 1Department of Pediatrics, and 2Oregon Evidence-based Practice Center, Oregon Health & Science University, Portland Ore 3Department of Pediatrics, University of Texas-Houston Health Science Center, Houston TX 4Department of Primary Care Research, Olmsted Medical Center, Rochester Minn Corresponding author: Scott A. Shipman, MD, MPH Department of Pediatrics Oregon Health & Science University 707 SW Gaines Rd., CDRC-P Portland, OR 97239 Phone: (503) 494-6542 FAX: (503) 494-4953 Email: [email protected] Abstract Background: Developmental dysplasia of the hip (DDH) represents a spectrum of anatomic abnormalities that can result in permanent disability. Objective: We sought to gather and synthesize the published evidence regarding screening for DDH by primary care providers. Methods: We performed a systematic review of the literature using a best evidence approach as used by the U.S. Preventive Services Task Force. The review focused on screening relevant to primary care in infants from birth to 6 months of age, and on interventions employed before 1 year of age. Results: The literature on screening and interventions for DDH suffers from significant methodological shortcomings. No published trials directly link screening to improved functional outcomes. Clinical examination and ultrasound identify somewhat different groups of newborns at risk for DDH. A significant proportion of hip abnormalities identified through clinical examination or ultrasound in the newborn period will spontaneously resolve. Very few studies examine the functional outcomes of patients who have undergone therapy for DDH.
    [Show full text]
  • Maternal-Newborn Nursing Demystified Downloaded by [ Faculty of Nursing, Chiangmai University 5.62.156.86] at [07/18/16]
    Downloaded by [ Faculty of Nursing, Chiangmai University 5.62.156.86] at [07/18/16]. Copyright © McGraw-Hill Global Education Holdings, LLC. Not to be redistributed or modified in any way without permission. Downloaded by [ Faculty of Nursing, Chiangmai University 5.62.156.86] at [07/18/16]. Copyright © McGraw-Hill Global Education Holdings, LLC. Not to be redistributed or modified in any way without permission. Maternal-Newborn Nursing Demystified Downloaded by [ Faculty of Nursing, Chiangmai University 5.62.156.86] at [07/18/16]. Copyright © McGraw-Hill Global Education Holdings, LLC. Not to be redistributed or modified in any way without permission. Notice Medicine is an ever-changing science. As new research and clinical experience broaden our knowledge, changes in treatment and drug therapy are required. The author and the publisher of this work have checked with sources believed to be reliable in their efforts to provide informa- tion that is complete and generally in accord with the standards accepted at the time of publication. However, in view of the possibility of human error or changes in medical sciences, neither the author nor the publisher nor any other party who has been involved in the preparation or publi- cation of this work warrants that the information contained herein is in every respect accurate or complete, and they disclaim all responsibility for any errors or omissions or for the results obtained from use of the information contained in this work. Readers are encouraged to confirm the information contained herein with other sources. For example and in particular, readers are advised to check the product information sheet included in the package of each drug they plan to administer to be certain that the information contained in this work is accurate and that changes have not been made in the recommended dose or in the contraindications for administration.
    [Show full text]
  • Case Files Orthopaedic Surgery
    CASE FILES® Orthopaedic Surgery Eugene C. Toy, MD Timothy T. Roberts, MD Vice Chair of Academic Affairs, Resident of Orthopaedic Surgery Department of Obstetrics and Division of Orthopaedic Surgery Gynecology Albany Medical Center The John S. Dunn, Senior Academic Albany, New York Chair and Program Director The Methodist Hospital Ob/Gyn Joshua S. Dines, MD Residency Program Orthopaedic Surgeon Houston, Texas Sports Medicine and Shoulder Service Clerkship Director, Clinical Professor Hospital for Special Surgery Department of Obstetrics and Gynecology New York, New York The University of Texas—Houston Assistant Professor of Orthopaedic Surgery Medical School Weill Cornell Medical College Houston, Texas New York, New York Andrew J. Rosenbaum, MD Resident of Orthopaedic Surgery Division of Orthopaedic Surgery Albany Medical Center Albany, New York New York Chicago San Francisco Lisbon London Madrid Mexico City Milan New Delhi San Juan Seoul Singapore Sydney Toronto Copyright © 2013 by McGraw-Hill Education, LLC. All rights reserved. Except as permitted under the United States Copyright Act of 1976, no part of this publication may be reproduced or distributed in any form or by any means, or stored in a database or retrieval system, without the prior written permission of the publisher. ISBN: 978-0-07-179029-1 MHID: 0-07-179029-2 The material in this eBook also appears in the print version of this title: ISBN: 978-0-07-179030-7, MHID: 0-07-179030-6. All trademarks are trademarks of their respective owners. Rather than put a trademark symbol after every occurrence of a trademarked name, we use names in an editorial fashion only, and to the benefi t of the trademark owner, with no intention of infringement of the trademark.
    [Show full text]
  • Developmental Dysplasia of the Hip of the Dysplasia
    Developmental Dysplasia of the Hip Developmental Dysplasia of the Hip Anastacio Kotzias-Neto, MD Anastacio Kotzias-Neto, Bowen, MD J. Richard J. Richard Bowen, MD Anastacio Kotzias-Neto, MD Published by www.datatrace.com Data Trace Publishing Company DEVELOPMENTAL DYSPLASIA OF THE HIP By J. Richard Bowen, MD Anastacio Kotzias-Neto, MD Frontmatter.pmd 1 3/3/2006, 7:21 PM Copyright © 2006 Data Trace Publishing Company All rights reserved, First Edition Printed in the United States of America Published by Data Trace Publishing Company P.O. Box 1239 Brooklandville, Maryland 21022-9978 410-494-4994 Fax: 410-494-0515 ISBN 1-57400-108-6 Library of Congress Cataloging-in-Publication Data Developmental dysplasia of the hip / by J. Richard Bowen, Anastacio Kotzias-Neto.— 1st ed. p. ; cm. Includes bibliographical references and index. ISBN 1-57400-108-6 1. Hip joint—Dislocation—Treatment. 2. Hip joint—Dislocation—Surgery. 3. Pediatric orthopedics. [DNLM: 1. Hip Dislocation, Congenital—surgery. 2. Hip Dislocation, Congenital—therapy. 3. Orthopedic Procedures. WE 860 B786d 2006] I. Kotzias-Neto, Anastacio. II. Title. RD772.B69 2006 617.5'81—dc22 2005034950 Frontmatter.pmd 2 3/3/2006, 7:21 PM CONTENTS CHAPTER 1: INTRODUCTION . 1 DISEASE HISTORY OF DDH . 1 EMBRYOLOGY . 13 ETIOLOGY . 18 INCIDENCE . 22 ANATOMY OF THE HIP . 24 RADIOGRAPHIC MEASUREMENTS . 31 BLOOD AND NERVE SUPPLY TO THE HIP . 41 CHAPTER 2: THE NATURAL HISTORY OF DDH . 47 NATURAL HISTORY OF DYSPLASIA WITHOUT SUBLUXATION . 47 NATURAL HISTORY OF SUBLUXATION . 49 NATURAL HISTORY OF COMPLETE DISLOCATION . 50 CHAPTER 3: DIAGNOSIS OF DDH . 53 EARLY DIAGNOSIS (BIRTH TO 3 MONTHS OF AGE) .
    [Show full text]
  • 5. Developmental Dysplasia of Hip 5.1 Introduction Developmental Dysplasia of the Hip (DDH) Is a Condition That Affects the Neonatal and Infant Hip Joint
    5. Developmental Dysplasia of Hip 5.1 Introduction Developmental Dysplasia of the Hip (DDH) is a condition that affects the neonatal and infant hip joint. DDH is a term used to describe a spectrum of abnormalities affecting the relationship of the femoral head (top part of thigh bone) to the acetabulum (socket). In many circumstances, symptoms of DDH may be present at birth, however at times it may resolve within the first weeks of life. Alternatively, the hip may be stable at birth and develop an abnormality later hence the use of the term Developmental Dysplasia of the Hip (DDH), rather than Congenital Dysplasia of the Hip (CDH), as this condition was previously known. These may include an immature hip, a hip with mild acetabular dysplasia, a hip that is dislocatable, a hip that is subluxated, or a hip that is frankly dislocated. The identification of risk factors, including breech presentation and family history, should heighten a physician’s suspicion of developmental dysplasia of the hip. Diagnosis is made by physical examination. Palpable hip instability, unequal leg lengths, and asymmetric thigh skinfolds may be present in newborns with a hip dislocation, whereas gait abnormalities and limited hip abduction are more common in older children. Hip dysplasia refers to an abnormality in the size, shape, orientation, or organization of the femoral head, acetabulum, or both. RESOURCE MATERIAL: Rashtriya Bal Swasthya Karyakram (RBSK) | 99 Acetabular dysplasia is characterized by an immature, shallow acetabulum and can result in subluxation or dislocation of the femoral head. In a sub-luxed hip, the femoral head is displaced from its normal position but still makes contact with a portion of the acetabulum.
    [Show full text]
  • Infant with an Abnormal Hip Exam 1. Background: Routine Neonatal Screening for Developmental Dysplasia of the Hip (DDH) Is Very Important in All Newborns
    Infant with an Abnormal Hip Exam 1. Background: Routine neonatal screening for developmental dysplasia of the hip (DDH) is very important in all newborns. DDH refers to abnormal development of the hip where there is instability (dislocatability) of the hip and dysplasia (abnormal shape) of the acetabulum. Physical examination using the Barlow and Ortolani tests are frequently positive in individuals with DDH, however it is not pathognomonic for dysplasia/dislocation of the femoral head in the acetabulum. Rather, the presence of an abnormal physical exam warrants immediate further investigation and possible intervention. This article outlines the epidemiology, risk factors, signs and symptoms, diagnosis, and treatment of DDH as well as its complications and differential diagnoses. 2. Epidemiology and Risk Factors DDH affects one in one thousand live births and most commonly in occurs in otherwise healthy infants. Laxity of the hip and immaturity of the development of the acetabulum is often detected in normal newborns in the first few weeks of life. This laxity resolves in most cases and acetabulum goes on to develop normally. The cause of DDH in most cases is unknown, but presumed to be multifactorial despite many competing theories that attempt to explain its etiology. DDH can however occur in association with other conditions such as Ehlers-Danlos, Down Syndrome and various forms of neuromuscular hip dysplasia. Other causes of DDH are by teratogens during the gestational period. Risk factors for DDH include female gender, breech presentation, and a positive family history of DDH. Girls with a breech presentation are at the highest risk with an estimated risk of 12%.
    [Show full text]
  • View the 2020 Index
    Index A Abruptio placentae, 640 for osteoarthritis, 466 Acid phosphatase in neutrophils, 406 A-a gradient cocaine use, 614 toxicity effects, 485 Acid reflux by age, 668 preeclampsia, 643 toxicity treatment for, 248 H2 blockers for, 399 with oxygen deprivation, 669 Abscesses, 479 Acetazolamide, 252, 552, 608 proton pump inhibitors for, 399 restrictive lung disease, 675 acute inflammation and, 214 pseudotumor cerebri, 521 Acid suppression therapy, 398 Abacavir, 203 brain, 156, 177, 180 Acetoacetate metabolism, 90 Acinetobacter baumannii Abciximab calcification with, 211 Acetone breath, 347 highly resistant bacteria, 198 Glycoprotein IIb/IIIa inhibitors, cold staphylococcal, 116 Acetylation nosocomial infections, 142 438 frontal lobe, 153 chromatin, 34 Acinetobacter spp therapeutic antibodies, 122 Klebsiella spp, 145 drug metabolism, 232 nosocomial infections, 185 thrombogenesis and, 411 liver, 155, 179 histones, 34 Acne, 475, 477 Abdominal aorta lung, 685 posttranslation, 45 danazol, 658 atherosclerosis in, 302 necrosis with, 209 Acetylcholine (ACh) tetracyclines for, 192 bifurcation of, 663 Staphylococcus aureus, 135 anticholinesterase effect on, 240 Acquired hydrocele (scrotal), 652 branches, 363 Toxoplasma gondii, 177 change with disease, 495 Acrodermatitis enteropathica, 71 Abdominal aortic aneurysm, 302 treatment of lung, 192 Clostridium botulinum inhibition Acromegaly, 339 Abdominal pain in unvaccinated children, 186 of release, 138 carpal tunnel syndrome, 459 bacterial peritonitis, 390 Absence seizures opioid analgesics, 551 GH, 329
    [Show full text]
  • Special Tests
    Special Tests Joint Structure/Disorder/Injury Special Test Jaw TMJ Syndrome/Dysfunction Bite/Cotton Roll Test Cervical Spine Alar Ligament Alar Ligament Stress Test Atlantoaxial Joint (C1/2 Dysfunction) Cervical Flexion Rotation Test Autonomic Nervous System Valsalva Maneuver Cervicogenic Headache Cervical Flexion Rotation Test Deep Cervical Flexors Craniocervical Flexion Test Neck Flexor Endurance Test Disc or Facet Dysfunction Compression/Distraction Test Fracture Rotation < 45 degrees Neural Tension Upper Limb Tension Test Radiculopathy Distraction Test Rotation < 60 degrees Spurling’s Test ULPT 1 Transverse Ligament Sharp Purser Test Transverse Ligament Stress Test Vertebrobasilar Artery Insufficiency Neck Extension-Rotation Test Thoracic Spine First Rib Hypomobility Cervical Rotation Lateral Flexion Test Limited Chest Expansion Thoracic Excursion Neural Tension Slump Test Thoracic Outlet Syndrome Adson Maneuver Allen Test Costoclavicular Syndrome Test Halstead Test Roos Test Wright Test (Hyperabduction Test) Lumbar Spine/ Force Closure Problem Supine/Prone ASLR with Muscle Challenge Pelvis Form Closure Problem Supine/Prone ASLR with Manual Stability Innominate (Anteriorly Stuck) Standing March Test Supine to Long Sit (Long à Short) Innominate (Posteriorly Stuck) Forward Bend Test Supine to Long Sit (Short à Long) Instability H and I Test Lumbar Torsion Test Passive Lumbar Extension Test Prone Segmental Instability Test Neural Tension Centralization/Peripheralization Test Femoral Nerve Traction Test Prone Knee Bend Test Slump Test
    [Show full text]
  • Screening for Developmental Dysplasia of the Hip
    Evidence Synthesis Number 42 Screening for Developmental Dysplasia of the Hip U.S. Department of Health and Human Services Agency for Healthcare Research and Quality www.ahrq.gov This report may be used, in whole or in part, as the basis for development of clinical practice guidelines and other quality enhancement tools, or a basis for reimbursement and coverage policies. AHRQ or U.S. Department of Health and Human Services endorsement of such derivative products may not be stated or implied. AHRQ is the lead Federal agency charged with supporting research designed to improve the quality of health care, reduce its cost, address patient safety and medical errors, and broaden access to essential services. AHRQ sponsors and conducts research that provides evidence-based information on health care outcomes; quality; and cost, use, and access. The information helps health care decisionmakers—patients and clinicians, health system leaders, and policymakers—make more informed decisions and improve the quality of health care services. Evidence Synthesis Number 42 Screening for Developmental Dysplasia of the Hip Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 540 Gaither Road Rockville, MD 20850 http://www.ahrq.gov Contract No. 290-02-0024 Task No. 2 Technical Support of the U.S. Preventive Services Task Force Prepared by: Oregon Evidence-based Practice Center Oregon Health and Science University 3181 SW Sam Jackson Park Road Portland, Oregon 97239 Scott Shipman, MD, MPH, Principal Investigator Mark Helfand, MD, MPH, Co-Investigator Peggy Nygren, MA, Research Associate Christina Bougatsos, Research Assistant March 2006 Preface The agency for Healthcare Research and Quality (AHRQ) sponsors the development of Evidence Syntheses through its Evidence-based Practice Program.
    [Show full text]
  • View the 2021 Index
    Index A ABO hemolytic disease of newborn, idiopathic intracranial Acinetobacter baumannii A-a gradient 415 hypertension, 540 highly resistant bacteria, 198 by age, 692 Abortion mechanism, use and adverse Acne, 489, 491 in oxygen deprivation, 693 antiphospholipid syndrome, 482 effects, 631 danazol, 682 restrictive lung disease, 699 ethical situations, 276 sulfa drug, 255 tetracyclines for, 192 with oxygen deprivation, 693 methotrexate for, 450 Acetoacetate metabolism, 90 Acquired hydrocele (scrotal), 676 Abacavir Abruptio placentae, 664 Acetylation Acrodermatitis enteropathica, 71 HIV terapy, 203 cocaine use, 638 chromatin, 34 Acromegaly HLA subtype hypersensitivity, 100 preeclampsia, 667 drug metabolism, 234 carpal tunnel syndrome, 470 Abciximab Abscesses, 493 histones, 34 findings, diagnosis and treatment, antiplatelets, 447 acute inflammation and, 215 posttranslation, 45 347 mechanism and clinical use, 447 brain, 156, 180 Acetylcholine (ACh) GH, 337 thrombogenesis and, 421 calcification with, 212 anticholinesterase effect on, 244 GH analogs, 336 Abdominal aorta cold staphylococcal, 116 change with disease, 510 octreotide for, 410 and branches, 373 frontal lobe, 153 Clostridium botulinum inhibition somatostatin analogs for, 336 atherosclerosis in, 310 Klebsiella spp, 145 of release, 138 Actin bifurcation of, 687 Staphylococcus aureus, 135 pacemaker action potential and, cytoskeleton, 48, 61 Abdominal aortic aneurysm, 310 liver, 155, 179 301 muscular dystrophies, 61 Abdominal pain lung, 709 Acetylcholine (ACh) receptor Acting out, 576
    [Show full text]